2014年3月27日星期四

Bpc 15 ,Bpc 157 ,Bpc-157 ,Booly protection compound 15 ,BPC-15 ,C62H98


Bpc 15 
Bpc 157 
Bpc-157 
Booly protection compound 15 
BPC-15 
C62H98N16O22
LS-172994
L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-
137525-51-0

[Structure]
Bpc 15 ,Bpc 157 ,Bpc-157 ,Booly protection compound 15 ,BPC-15 ,C62H98

[ Properties Computed from Structure] 
Molecular Weight1419.53552 [g/mol]
Molecular FormulaC62H98N16O22
XLogP-8.1
H-Bond Donor16
H-Bond Acceptor24
Rotatable Bond Count39
Tautomer Count1001
Exact Mass1418.704159
MonoIsotopic Mass1418.704159
Topological Polar Surface Area574
Heavy Atom Count100
Formal Charge0
Complexity3040
Isotope Atom Count0
Defined Atom StereoCenter Count11
Undefined Atom StereoCenter Count1
Defined Bond StereoCenter Count0
Undefined Bond StereoCenter Count0
Covalently-Bonded Unit Count1

[ Descriptors Computed from Structure] 
IUPAC Name: (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[6-amino-1-
[(2S)-2-[[(2S)-1-[[(2S)-4-hydroxy-1-[[(2S)-4-hydroxy-1-[[(2S)-1-[[2-[[
(2S)-1-[[(2S)-1-hydroxy-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-
oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1,
4-dioxobutan-2-yl]amino]-1,
4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-
oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]
pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
Canonical SMILES: CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC
(=O)O)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C2CCCN2C(=O)
C3CCCN3C(=O)C4CCCN4C(=O)C(CCC(=O)O)NC(=O)CN
Isomeric SMILES: CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]
(CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)C
(CCCCN)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)
[C@H](CCC(=O)O)NC(=O)CN
InChI: InChI=1/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46
(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-
52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-
66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77
(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,
1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,
72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,
35u,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1/f/h65-74,82,84,86,99H



Company Name: PhtdPeptides. Co., Ltd.
Contact: William wang
Email: phtd012@phtdpeptides.com
web:   www.phtdpeptides.com
Skype: william39333
QQ:329284319
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230

BPC 157 (Body Protection Compound-157)

BPC 157 (Body Protection Compound-157)



 BPC 157 (Body Protection Compound-157) is a pentadecapeptide made up of 15 amino acids. The amino acids sequence in BPC 157 is similar to a portion of the human BPC amino acid sequence. Human BPC is found in the gastric juice. Experiments have shown that BPC 157 enhances the healing of wounds, including tendons wounds such as transected Achilles tendons of rats. The aim of this study was to investigate the probable mechanism that BPC 157 utilizes to accelerate the healing process in an injured tendon. The study used two group of tendon explants of which one group was cultured in a BPC 157-containing medium while the other group was cultured in a medium lacking BPC 157. These cultures were thereafter examined for tendon fibroblasts outgrowths. Such outgrowths indicated tendon regeneration.
            The results revealed that the explants’ outgrowth was significantly accelerated in the culture containing BPC 157 as compared to the culture lacking BPC 157. Also, a MTT assay did show that BPC 157 does not directly affect cellular proliferation in a culture of rat-derived Achilles tendon. However, results also showed that BPC 157 significantly increased the survival of cells under oxidative stress. Furthermore, the Transwell filter migration assay showed that BPC 157 significantly increased in-vitro fibroblast migration in a dose-dependent fashion. Moreover, BPC 157 accelerated the dispersal of the fibroblasts in culture dishes in a dose-dependent manner.
            Additionally, FITC-phalloidin staining was able to demonstrate that BPC 157 induces F-actin formation in fibroblasts. Likewise, Western blot analysis was able to detect the production and activation of paxillin and FAK proteins. The western blot analysis also showed that BPC 157 increases the extent of phosphorylation of paxillin and FAK proteins without affecting the amounts produced.
            Thus, it can be concluded that BPC 157 enhances the ex-vivo growth and in-vitro cellular migration of fibroblasts derived from rat tendon explants. Moreover, BPC 157 also increases the probability of a cell surviving under oxidative stress. These actions of BPC 157 are probably mediated by the activation (through phosphorylation) of the proteinic FAK-paxillin pathway.  


Company Name: PhtdPeptides. Co., Ltd.
Contact: William wang
Email: phtd012@phtdpeptides.com
web:   www.phtdpeptides.com
Skype: william39333
QQ:329284319
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230

2014年3月26日星期三

Adipotide and the Bad Fat

Adipotide and the Bad Fat

Just a brief respite from mitochondria:

Adipotide is a drug which targets the blood vessels supplying adipose tissue. It causes impressive fat loss by killing fat cells. Anon posted these two links on the last post.

There are other processes which can produce adipocyte destruction. We've discussed both acquired and congenital lipodystrophes in the past. They produce whole body fat loss with progressively deteriorating glucose tolerance because fatty acids have no adipocytes to enter, so end up accumulating in all tissues, producing pathological insulin resistance and diabetes. This is basic physiology and exactly what you would expect.

Adipotide is different. It produces fat loss with improving metabolic conditions and decreased hunger. How come a dead adipocyte is good from Adipotide and bad from auto immune attack?

Alex emailed me the full text. Here is the snippet from the email conversation which was my initial take on what might be happening:

"How does the drug get any improvement? You'd need to see the data and how they generated it but if the drug preferentially targets abdominal fat there would be an improvement in systemic insulin resistance until enough total [whole body] fat cells were lost for the overall for deterioration in insulin sensitivity due to muscle lipid accumulation to precipitate diabetes.

Of course during lipolysis you would have FFA release acting like an obese fat cell becoming insulin resistant and sending FFAs systemically to most non CNS mitochondria... Reduced need for food and increased ATP for activity from the metabolic flexibility perspective..."

Look here: Surgical removal of visceral fat improves peripheral insulin sensitivity (there's a lot I could write about this paper but no time). This paper looks OK, other papers by this group are very dubious.

Visceral fat seems quite important, here's an early brief review.

And here is the only quote we need from the Adipotide paper (thank you Alex for the full text):

"MRI and DEXA imaging confirmed that weight loss in the rhesus monkeys occurred primarily because of visceral fat loss."


Now, that's all hunky dory. What is the question we need to ask? Actually, there are a few:

Why is visceral fat Bad Fat? Why do we make it? If we get rid of the Bad Fat, will health be Good for ever? Did we evolve Bad Fat to kill ourselves? Is there a survival benefit from Bad Fat if we continue to drink >30% of our calories from fructose based drinks? Would having our omentum removed do good or bad things long term if we continue to mainline fructose? Would we need to get rid of our Bad Fat if we poured the Fanta down the urinal rather than down our throats?

I rather like Bad Fat. It opens all sorts of avenues of thought. There's so much about it that fits together but no more time to blog at the moment.

Company Name: PhtdPeptides. Co., Ltd.
Contact: William wang
Email: phtd012@phtdpeptides.com
web:   www.phtdpeptides.com
Skype: william39333
QQ:329284319
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230

peptide d

peptide d


C- Myc peptide epitope53597Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu
C. difficile Toxin B (192-207)86634Ala-Gln-Arg-Glu-Glu-Asn-Pro-Glu-Leu-Ile-Ile-Asp-Asp-Ile-Val-Lys
C. difficile Toxin B (232-241)86633Ile-Thr-Gln-Asn-Ser-Gly-Asn-Asp-Val-Arg
C. difficile Toxin B (248-262)86632Asn-Gly-Glu-Ser-Phe-Asn-Leu-Tyr-Glu-Gln-Glu-Leu-Val-Glu-Arg
C. difficile Toxin B (392-401)86631Asp-Ser-Tyr-Cys-Ser-Asn-Leu-Ile-Val-Lys
C. difficile Toxin B (529-536)86630Ala-Gln-Phe-Glu-Glu-Tyr-Lys-Arg
C. difficile Toxin B (8-16)86629Gln-Leu-Glu-Lys-Met-Ala-Asn-Val-Arg
C3 Peptide P1688502Lys-Asn-Arg-Trp-Glu-Asp-Pro-Gly-Lys-Gln-Leu-Tyr-Asn-Val-Glu-Ala
C3a (70-77)57537Ala-Ser-His-Leu-Gly-Leu-Ala-Arg
C3a (72-77) (human)55068His-Leu-Gly-Leu-Ala-Arg
Cadherin Peptide, avian88503Leu-Arg-Ala-His-Ala-Val-Asp-Val-Asn-Gly-NH2
Caerulein (desulfated)89391Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-Phe-NH2
Calcineurin Autoinhibitory Fragment55228Ile-Thr-Ser-Phe-Glu-Glu-Ala-Lys-Gly-Leu-Asp-Arg-Ile-Asn-Glu-Arg-Met-Pro-Pro-Arg-Arg-Asp-Ala-Met-Pro
Calcineurin Substrate51014Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu
Calcitonin (8-32) (salmon I)89395Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2
Calcitonin C-terminal Adjacent Peptide, rat88245Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn
Calcitonin Gene Related Peptide (8-37), human55279Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2
Calcitonin Gene Related Peptide (8-37), human55279Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2
Calcitonin Gene Related Peptide (8-37), rat55280Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2
Calcitonin Gene Related Peptide II, human52232Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7)
Calcitonin Gene Related Peptide II, rat55205Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala- Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7)
Calcitonin Gene Related Peptide, chicken55202Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala- Asp-Phe-Leu-Ser-Arg-Ser-Gly-Gly-Val-Gly-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7)
Calcitonin Gene Related Peptide, rat55203Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7)
Calcitonin N-Terminal Flanking Peptide, human N – Procalcitonin88246Ala-Pro-Phe-Arg-Ser-Ala-Leu-Glu-Ser-Ser-Pro-Ala-Asp-Pro-Ala-Thr-Leu-Ser-Glu-Asp-Glu-Ala-Arg-Leu-Leu-Leu-Ala-Ala-Leu-Val-Gln-Asp-Tyr-Val-Gln-Met-Lys-Ala-Ser-Glu-Leu-Glu-Gln-Glu-Gln-Glu-Arg-Glu-Gly-Ser-Ser-Leu-Asp-Ser-Pro-Arg-Ser
Calcitonin, chicken55431Cys-Ala-Ser-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser- Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val- Gly-Ala-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7
Calcitonin, chicken100890Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-nh2
Calcitonin, eel55430Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser- Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val- Gly-Ala-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7)
Calcitonin, human52229Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge: Cys1-Cys7)
Calcitonin, porcine88247Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Ser-Ala-Tyr-Trp-Arg-Asn-Leu-Asn-Asn-Phe-His-Arg-Phe-Ser-Gly-Met-Gly-Phe-Gly-Pro-Glu-Thr-Pro-NH2 (Disulfide bridge: Cys1-Cys7)
Calcitonin, rat55432Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr- Gln-Asp-Leu-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ser-Ile- Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge:Cys1-Cys7)
Calcitonin, salmon52230Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide bridge Cys1-Cys7)
Calcium//Calmodulin Dependent Protein Kinase II-g (345-358)86885Lys-Ser-Asp-Gly-Gly-Val-Lys-Lys-Arg-Lys-Ser-Ser-Ser-Ser
Calcium-Like Peptide84913Val-Ala-Ile-Thr-Val-Leu-Val-Lys
Calmodulin-Dependent Protein Kinase II (281-289)59757Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys
Calmodulin-Dependent Protein Kinase II (281-309)101417Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala
Calmodulin-Dependent Protein Kinase II (290-309)57423Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala
Caloxin 2A154557Val-Ser-Asn-Ser-Asn-Trp-Pro-Ser-Phe-Pro-Ser-Ser-Gly-Gly-Gly-NH2
Calpain Inhibitor Peptide102027Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala
cAMP Dependent PK Inhibitor (5-22), amide101416Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2
cAMP Dependent PK Inhibitor (5-24)62306Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp
cAMP Dependent Protein Kinase Substrate86886Arg-Arg-Lys-Ala-Ser-Gly-Pro
CAP-18, rabbit88322Gly-Leu-Arg-Lys-Arg-Leu-Arg-Lys-Phe-Arg-Asn-Lys-Ile-Lys-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Gln-Gly-Leu-Leu-Pro-Lys-Leu-Ala-Pro-Arg-Thr-Asp-Tyr
Carassin (Carrassius Auratus)89063Ser-Pro-Ala-Asn-Ala-Gln-Ile-Thr-Arg-Lys-Arg-His-Lys-Ile-Asn-Ser-Phe-Val-Gly-Leu-Met-NH2
Casein Kinase II Assay Kit52539Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp
Casein Kinase II Receptor Peptide101408Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu
Casein Kinase II Substrate54377Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu
Caspase 1 Substrate 1 (ICE), chromogenic Ac-YEVD-pNA101338Ac-Tyr-Glu-Val-Asp-pNA
Caspase 1 Substrate 1m (ICE), fluorogenic Ac-YEVD-AMC101339Ac-Tyr-Glu-Val-Asp-AMC
Caspase 1 Substrate 2m (ICE), fluorogenic Ac-YVAD-AMC101341Ac-Tyr-Val-Ala-Asp-AMC
Caspase 2 Substrate 1m (ICH-1), fluorogenic Ac-VDVAD-AMC101342Ac-Val-Asp-Val-Ala-Asp-AMC
Caspase 2 Substrate, chromogenic Ac-VDQQD-pNA101340Ac-Val-Asp-Gln-Gln-Asp-pNA
Caspase 3 Substrate 1m (Apopain), fluorogenic Ac-DEVD-AMC101344Ac-Asp-Glu-Val-Asp-AMC
Caspase 3 Substrate, chromogenic Ac-VQVD-pNA101343Ac-Val-Gln-Val-Asp-pNA
Caspase 3 Substrate, Colorimetric51546Ac-Asp-Glu-Val-Asp-pNA
Catch-Relaxing Peptide (CARP)55307Ala-Met-Pro-Met-Leu-Arg-Leu-NH2
Cathepsin G (77-83)100801His-Pro-Gln-Tyr-Asn-Gln-Arg
Cathepsin S substrate100802Ac-Lys-Gln-Lys-Leu-Arg-AMC
Cathepsin S substrate100802Ac-Lys-Gln-Lys-Leu-Arg-AMC
CB-TH51613Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Gly-Ser-Tyr-Cys-Asn-Arg-Arg-Thr-Gly-Lys-Cys-Gln-Arg-Met
CC Chemokine Receptor 3 Fragment I, amide86745Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-Glu-Lys-Ala-Asp-Thr-Arg-NH2
CC Chemokine Receptor 3 Fragment II86746Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys
CC Chemokine Receptor 3 Fragment II, amide86747Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-NH2
CD36 (93-110)-Cys73061Tyr-Arg-Val-Arg-Phe-Leu-Ala-Lys-Glu-Asn-Val-Thr-Gln-Asp-Ala-Glu-Asp-Asn-Cys
CDC25C62025Lys-Lys-Lys-Val-Ser-Arg-Ser-Gly-Leu-Tyr-Arg-Ser-Pro-Ser-Met-Pro-Glu-Asn-Leu-Asn-Arg-Pro-Arg
CDPKS, Syntide analog86715Pro-Leu-Arg-Arg-Thr-Leu-Ser-Val-Ala-Ala
CDR-H3//C289423Cys-Asp-Leu-Ile-Tyr-Tyr-Asp-Tyr-Glu-Glu-Asp-Tyr-Tyr-Phe-Asp-Cys (Disulfide bridge: Cys1-Cys16)
CEA (605-613)51175Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu
CEA Related, QYSWFVNGTF54748Gln-Tyr-Ser-Trp-Phe-Val-Asn-Gly-Thr-Phe
CEA Related, TYACFVSNL54749Thr-Tyr-Ala-Cys-Phe-Val-Ser-Asn-Leu
CEA, CAP-1-6-D, [Asp6]-Carcinoembryonic Antigen51102Tyr-Leu-Ser-Gly-Ala-Asp-Leu-Asn-Leu
Cecropin A61318Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Gln-Asn-Ile-Arg-Asp-Gly-Ile-Ile-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Thr-Gln-Ile-Ala-Lys-NH2
Cecropin A (1-7)-Melittin A (2-9) amide89424Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-NH2
Cecropin A (1-8)-Melittin (1-18) amide54694Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-NH2
Cecropin B55297Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-NH2
Cecropin B, Free Acid70679Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu
Cecropin P1 (porcine)89425Ser-Trp-Leu-Ser-Lys-Thr-Ala-Lys-Lys-Leu-Glu-Asn-Ser-Ala-Lys-Lys-Arg-Ile-Ser-Glu-Gly-Ile-Ala-Ile-Ala-Ile-Gln-Gly-Gly-Pro-Arg
CEF1055321Cys-Leu-Gly-Gly-Leu-Leu-Thr-Met-Val
CEF355330Ser-Ile-Ile-Pro-Ser-Gly-Pro-Leu-Lys
CEF455361Arg-Val-Leu-Ser-Phe-Ile-Lys-Gly-Thr-Lys
CEF655329Leu-Pro-Phe-Asp-Lys-Thr-Thr-Val-Met
Ceratotoxin A89426Ser-Ile-Gly-Ser-Ala-Leu-Lys-Lys-Ala-Leu-Pro-Val-Ala-Lys-Lys-Ile-Gly-Lys-Ile-Ala-Leu-Pro-Ile-Ala-Lys-Ala-Ala-Leu-Pro
Ceratotoxin B89427Ser-Ile-Gly-Ser-Ala-Phe-Lys-Lys-Ala-Leu-Pro-Val-Ala-Lys-Lys-Ile-Gly-Lys-Ala-Ala-Leu-Pro-Ile-Ala-Lys-Ala-Ala-Leu-Pro
Cerebellin55155H-Ser-Gly-Ser-Ala-Lys-Val-Ala-Phe-Ser-Ala-Ile-Arg-Ser-Thr-Asn-His-OH
CFP10 (71-85)88354Glu-Ile-Ser-Thr-Asn-Ile-Arg-Gln-Ala-Gly-Val-Gln-Tyr-Ser-Arg
CFTR (108-117), Pseudomonas aeruginosa Inhibitor88355Ser-Tyr-Asp-Pro-Asp-Asn-Lys-Glu-Glu-Arg
Charybdotoxin101407Glp-Phe-Thr-Asn-Val-Ser-Cys-Thr-Thr-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Gln-Arg-Leu-His-Asn-Thr-Ser-Arg-Gly-Lys-Cys-Met-Asn-Lys-Lys-Cys-Arg-Cys-Tyr-Ser (Disulfide bridges:Cys7-Cys28, Cys13-Cys33, Cys17-Cys35 )
Cholecystokinin Octapeptide (1-2) (desulfated)58076Asp-Tyr
Cholecystokinin Octapeptide (1-3) (desulfated)89432Asp-Tyr-Met
Cholecystokinin Octapeptide (1-4) (desulfated)89433Asp-Tyr-Met-Gly
Cholecystokinin Octapeptide (1-5) (desulfated)89434Asp-Tyr-Met-Gly-Trp
Cholecystokinin Octapeptide (1-6) (desulfated)89435Asp-Tyr-Met-Gly-Trp-Met
Cholecystokinin Octapeptide (2-8) (desulfated)89436Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2
Cholecystokinin Octapeptide (desulfated)76537Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2
Cholecystokinin Octapeptide free acid (desulfated)62358Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe
Cholecystokinin Precursor (107-115) (human) (desulfated)89439Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Pro-Ser
Cholecystokinin Precursor (24-32) (rat)89438Val-Pro-Val-Glu-Ala-Val-Asp-Pro-Met
Cholecystokinin-33 (10-20) (bovine, porcine)89441Ile-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His
Cholecystokinin-33 (1-21) (porcine)89440Lys-Ala-Pro-Ser-Gly-Arg-Val-Ser-Met-Ile-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His-Arg
Chorionic Gonadotropin-β(109-119) amide (human)89442Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-NH2
Chorionic Gonadotropin-β(109-145) (human)62542Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln
Chromogranin A (324-337), human88504Trp-Ser-Lys-Met-Asp-Gln-Leu-Ala-Lys-Glu-Leu-Thr-Ala-Glu
Chromostatin, bovine55166Ser-Asp-Glu-Asp-Ser-Asp-Gly-Asp-Arg-Pro-Gln-Ala-Ser-Pro-Gly-Leu-Gly-Pro-Gly-Pro
CK1tide86714His-Ala-Ala-Ile-Gly-Asp-Asp-Asp-Asp-Ala-Tyr-Ser-Ile-Thr-Ser-NH2
CKS-1755160Leu-Gln-Asn-Arg-Arg-Gly-Leu-Asp-Leu-Leu-Phe-Leu-Lys-Glu-Gly-Gly-Leu
CKS-17 (7-12)89443Leu-Asp-Leu-Leu-Phe-Leu
CLIP(85–99)88002Lys-Pro-Val-Ser-Gln-Met-Arg-Met-Ala-Thr-Pro-Leu-Leu-Met-Arg
Collagen Binding Fragment55360Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr
Complement anaphylatoxin C5a (37-53), human88240Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu
Conantokin G89530Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn-NH2
Conantokin G (free acid)89531Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn
Conantokin T, Marine snail, Conus tullpa101852Gly-Glu-Gla-Gla-Tyr-Gln-Lys-Met-Leu-Gla-Asn-Leu-Arg-Gla-Ala-Glu-Val-Lys-Lys-Asn-Ala-NH2
Conopressin S89533Cys-Ile-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge: Cys1-Cys6)
Contraceptive Tetrapeptide88505Thr-Pro-Arg-Lys
Corazonin, American Cockroach, Periplaneta americana55394Pyr-Thr-Phe-Gln-Tyr-Ser-Arg-Gly-Trp-Thr-Asn-NH2
Corticostatin, human87344Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val
Corticostatin, rabbit87343Gly-Ile-Cys-Ala-Cys-Arg-Arg-Arg-Phe-Cys-Pro-Asn-Ser-Glu-Arg-Phe-Ser-Gly-Tyr-Cys-Arg-Val-Asn-Gly-Ala-Arg-Tyr-Val-Arg-Cys-Cys-Ser-Arg-Arg
Corticotropin Releasing Factor, bovine55412Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Asn-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2
Corticotropin Releasing Factor, human, rat52234Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2
Corticotropin Releasing Factor, ovine55413Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2
Cortistatin 14 (mouse, rat)52235Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys(Disulfide bridge:Cys2-Cys13)
Cortistatin 17, human89043Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys (Disulfide bridge Cys5-Cys16)
C-Peptide (57-87), human51895Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln
C-Peptide 1 (rat)89543Glu-Val-Glu-Asp-Pro-Gln-Val-Pro-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Glu-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln
C-Peptide 2 (rat)89544Glu-Val-Glu-Asp-Pro-Gln-Val-Ala-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln
C-Peptide, dogs55238Glu-Val-Glu-Asp-Leu-Gln-Val-Arg-Asp-Val-Glu-Leu-Ala-Gly-Ala-Pro-Gly-Glu-Gly-Gly-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ala-Leu-Gln
C-Reactive Protein (CRP) (174-185)89547Ile-Tyr-Leu-Gly-Gly-Pro-Phe-Ser-Pro-Asn-Val-Leu
C-Reactive Protein (CRP) (201-206)89548Lys-Pro-Gln-Leu-Trp-Pro
C-Reactive Protein (CRP) (77-82)89546Val-Gly-Gly-Ser-Glu-Ile
CREB327 (113-126)86713Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-Lys-Ile-Leu-Asn-Asp
CREBtide51607Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg
CREBtide86712Gly-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-Lys-NH2
CRF (6-33) (human, rat)81503Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser
Cripto-1, CR-160896Cys-Pro-Pro-Ser-Phe-Tyr-Gly-Arg-Asn-Cys-Glu-His-Asp-Val-Arg-Lys-Glu
Crustacean Cardioactive Peptide (CCAP)88506Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys
Crustacean Cardioactive Peptide (CCAP), amide88507Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys-NH2
Crustacean Cardioactive Peptide, CCAP55269Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys(Disulfide bridge Cys3-Cys9)
Crustacean Erythrophore Concentrating Hormone102070Pyr-Leu-Asn-Phe-Ser-Pro-Gly-Trp-NH2
Crystalline55342Trp-Gly
CSP54352Glu-Met-Arg-Leu-Ser-Lys-Phe-Phe-Arg-Asp-Phe-Ile-Leu-Gln-Arg-Lys-Lys
CTAP55206D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(Disulfide bridge:Cys2-Pen7)
C-telopeptide55264Glu-Lys-Ala-His-Asp-Gly-Gly-Arg
C-terminal Proghrelin Isoform Peptide, mouse84171Arg-Arg-Gln-Leu-Thr-Ser-Asn-His-Gly-Gln-Ala
CTX IV (6-12)52236Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2
C-Type Natriuretic Peptide (1-22), human52233Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22)
C-Type Natriuretic Peptide (1-53) (human)89549Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide bridge:Cys37-Cys54)
C-Type Natriuretic Peptide, Chicken55271Gly-Leu-Ser-Arg-Ser-Cys-Phe-Gly-Val-Lys-Leu-Asp-Arg- Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22)
Cyclo ( - RADfK - ), RGD negative control126737cyclo-Arg-Gly-Asp-D-Phe-Lys
Cys-CD36 (139-155)67680Cys-Asn-Leu-Ala-Val-Ala-Ala-Ala-Ser-His-Ile-Tyr-Gln-Asn-Gln-Phe-Val-Gln
Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid β -Protein (33-40)89307Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val
Cys-Gly-Lys-Arg-Amyloid-β Protein (1-42)89296Cys-Gly-Lys-Arg-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (35-40)89309Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val
Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40)89308Cys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val
Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42)89310Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-Ile-Ala
Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (37-42)89311Cys-Gly-Lys-Lys-Gly-Gly-Gly-Val-Val-Ile-Ala
Cys-GM-CSF (17-31)89081Cys-Asn-Ala-Ile-Gln-Glu-Ala-Arg-Arg-Leu-Leu-Asn-Leu-Ser-Arg-Asp
Cys-β- Amyloid (12-28)87999Cys-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys
Cys-β- Amyloid (1-40)79774Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val
DAGO55194Tyr-D-Ala-Gly-N-Me-Phe-Gly-OL
D-Ala-D-Ala51527D-Ala-D-Ala
D-Ala-Leu88508D-Ala-Leu
Dansyl-Y-V-G51628Dansyl-Tyr-Val-Gly
DAP10 Signaling Fragment86748Pro-Ala-Gln-Glu-Asp-Gly-Lys-Val-Tyr-Ile-Asn-Met-Pro-Gly-Arg-Gly
D-D-D-D-D55184Asp-Asp-Asp-Asp-Asp
D-D-D-D-D-D55198Asp-Asp-Asp-Asp-Asp-Asp
Decorsin, Leech87186Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu
Defensin (human) HNP-288393Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys (Disulfide bridge: Cys1- Cys29, Cys3- Cys18, Cys8- Cys28)
Defensin-1 (human) HNP-181061Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys
Defensin-1 (human) HNP-1100512Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys (Disulfide bridges Cys2-Cys30, Cys4-Cys19, and Cys 9-29 )
Delicious Peptide88509Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala
Delta (Phospho) Sleep Inducing Peptide88510Trp-Ala-Gly-Gly-Asp-Ala-Ser(PO3H2)-Gly-Glu
Delta Sleep Inducing Peptide55319Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Delta-MSH101846Ser-Met-Glu-Val-Arg-Gly-Trp
Dendroaspis Natriuretic Peptide89582Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Arg-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala (Disulfide bridge Cys7-Cys23)
Dermenkephalin55315Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2
Dermorphin52238Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2
Desmopressin52240Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide bridge, Map1-Cys6)
Diazepam-Binding Inhibitor Fragment, human89044Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr-Gly-Lys
Doc- 6 (130-145)86694Gly-Val-Gln-Arg-Glu-Gln-Asn-Glu-Arg-Phe-Asn-Val-Tyr-Leu-Met-Pro
Dok- 5 (263-275)100805Leu-Pro-Arg-Ser-Ala-Tyr-Trp-Gln-His-Ile-Thr-Arg-Gln
Dok-4 (130-145)100803Gly-Val-Gln-Cys-Glu-Gln-Thr-Asp-Arg-Phe-Asn-Val-Phe-Leu-Leu-Pro
Dok-4 (263-275)100804Leu-Pro-Arg-Ser-Ala-Tyr-Trp-His-His-Ile-Thr-Gly-Ser
Dok-6 (263-275)100806Leu-Pro-Arg-Ser-Ala-Tyr-Trp-His-His-Ile-Thr-Arg-Gln
D-P70110Asp-Pro
DTrp-Gamma MSH88487Tyr-Val-Met-Gly-His-Phe-Arg-D-Trp-Asp-Arg-Phe-Gly
DYKDDDDK53577Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys
Dynorphin (2-17), amide, porcine88366Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2
Dynorphin A (1-10), amide, porcine88367Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-NH2
Dynorphin A (1-10), porcine88368Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro
Dynorphin A (1-11), porcine88369Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys
Dynorphin A (1-12), porcine88370Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu
Dynorphin A (1-13), amide, porcine88371Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-NH2
Dynorphin A (1-13), porcine68567Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys
Dynorphin A (1-17), (Prodynorphin 209-225), Porcine82939Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
Dynorphin A (13-17), porcine54024Lys-Trp-Asp-Asn-Gln
Dynorphin A (1-6), porcine62326Tyr-Gly-Gly-Phe-Leu-Arg
Dynorphin A (1-7), porcine88372Tyr-Gly-Gly-Phe-Leu-Arg-Arg
Dynorphin A (1-8), porcine88373Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile
Dynorphin A (1-9), porcine88374Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg
Dynorphin A (2-12), porcine88375Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu
Dynorphin A (2-13), porcine100518Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys
Dynorphin A (2-17), porcine88376Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
Dynorphin A (3-13), porcine88377Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys
Dynorphin A (3-8), porcine88378Gly-Phe-Leu-Arg-Arg-Ile
Dynorphin A (6-17), porcine88379Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
Dynorphin A (7-17), porcine88380Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
Dynorphin A (8-17), porcine88381Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
Dynorphin A (9-17), porcine88382Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
Dynorphin A amide, porcine88383Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2
Dynorphin B (1-9)88384Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe
dY-V-G53888D-Tyr-Val-Gly
E75, Her-2//neu (369-377)51879Lys-Ile-Phe-Gly-Ser-Leu-Ala-Phe-Leu
Ecdysis-Triggering Hormone (Manduca sexta)  Mas-ETH102038Ser-Asn-Glu-Ala-Ile-Ser-Pro-Phe-Asp-Gln-Gly-Met-Met-Gly-Tyr-Val-Ile-Lys-Thr-Asn-Lys-Asn-Ile-Pro-Arg-Met-NH2
EGF Receptor (988-993) (phosphorylated) (human)100295Asp-Ala-Asp-Glu-pTyr-Leu-NH2
EGF Receptor Substrate 1101377Asp-Ala-Asp-Glu-pTyr-Leu-Ile-Pro-Gln-Gln-Gly-Phe-Phe
EGF Receptor Substrate 266648Asp-Ala-Asp-Glu-pTyr-Leu-Ile-Pro-Gln-Gln-Gly
EGFR-derived peptide64992Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Lys
Egg Laying Hormone of Aplysia55299Ile-Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-Arg-Gln-Arg-Leu-Leu-Glu-Lys-NH2
Eglin c (41-49)89770Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr
Eglin c (60-63)-methyl ester89771Thr-Asn-Val-Val-Ome
E-I-L-D-V, human, bovine, rat88461Glu-Ile-Leu-Asp-Val
E-I-L-E-V-P-S-T51669Glu-Ile-Leu-Glu-Val-Pro-Ser-Thr
Elcatonin Acetate61717Ser-Asn-Leu-Ser-Thr-Asu-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro (Lactam bridge: Ser1-Asu6)
Eledoisin55392Pyr-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2
Eledoisin Related Peptide55248Lys-Phe-Ile-Gly-Leu-Met-NH2
EMP-1 (Epithelial Membrane Protein)88512Gly-Gly-Thr-Tyr-Ser-Cys-His-Phe-Gly-Pro-Leu-Thr-Trp-Val-Cys-Lys-Pro-Gln-Gly-Gly
Endokinin A//B86684Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2
Endokinin C (Human)54835Lys-Lys-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu-NH2
Endokinin D (Human)54836Val-Gly-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu-NH2
Endomorphin-155185Tyr-Pro-Trp-Phe-NH2
Endomorphin-255186Tyr-Pro-Phe-Phe-NH2
Endonuclease Antigenic Site52241Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys
Endothelin (16-21)89903His-Leu-Asp-Ile-Ile-Trp
Endothelin 2 (human, canine)55555Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr- Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge:Cys1-Cys15, Cys3-Cys11)
Endothelin 3, human, rat55554Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr- Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge:Cys1-Cys15, Cys3-Cys11)
Endothelin-1 (11-21)89900Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp (Disulfide bridge Cys1-Cys5)
Endothelin-1 (1-15), amide, human88394Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-NH2
Endothelin-1 (1-15), human88395Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys
Endothelin-1, human55553Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr- Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge:Cys1-Cys15, Cys3-Cys11)
Endotoxin Inhibitor102058Lys-Thr-Lys-Cys-Lys-Phe-Leu-Lys-Lys-Cys (Disulfide bridge:Cys4-Cys10 )
Enfuvirtide(T-20)51419Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2
ent-Amyloid b-Protein (1-42)89297D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-D-Ile-D-Ala
Entero-Hylambatin89064Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2
Enterostatin (pig, rat)52243Val-Pro-Asp-Pro-Arg
Enterostatin, human52242Ala-Pro-Gly-Pro-Arg
Eosinophilotactic Peptide102055Val-Gly-Ser-Glu
Eosinophilotactic Tetrapeptides86566Ala-Gly-Ser-Glu



Company Name: PhtdPeptides. Co., Ltd.
Contact: William wang
Email: phtd012@phtdpeptides.com
web:   www.phtdpeptides.com
Skype: william39333
QQ:329284319
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230